---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000033"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:44:18.717394+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Salarius Pharmaceuticals files prospectus supplement for ATM offering of up to $417,000

## Summary
- Filed prospectus supplement on March 10, 2025 for at-the-market offering of up to $417,000 of common stock.
- Offering conducted through Ladenburg Thalmann & Co. under existing S-3 registration statement (333-266589).
- Legal opinion from Hogan Lovells US LLP included as Exhibit 5.1.

## SEC filing metadata
- accession: 0001615219-25-000033
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/0001615219-25-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000033/flks-20250310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000033
- JSON: https://secwatch.observer/filing/0001615219-25-000033.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.